Innoviva, Inc. SEC filings INVA
Innoviva, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Nov 27, 2012. Its latest annual report, Form 10-K, was filed on Feb 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Nov 1, 2024 | — |
| CORRESP | Letter to the SEC | Sep 26, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 13, 2024 | — |
| SC TO-T/A | Filing | Aug 22, 2022 | — |
| SC TO-T/A | Filing | Aug 16, 2022 | — |
| SC TO-T | Filing | Jul 25, 2022 | — |
| SC TO-C | Filing | Jul 11, 2022 | — |
| 425 | Filing | Jul 11, 2022 | — |
| SC TO-T/A | Filing | Jul 8, 2022 | — |
| CORRESP | Letter to the SEC | Jun 17, 2022 | — |
| SC TO-T/A | Filing | Jun 17, 2022 | — |
| SC TO-T | Filing | Jun 7, 2022 | — |
| SC TO-C | Filing | May 24, 2022 | — |
| SC TO-C | Filing | May 24, 2022 | — |
| DFAN14A | Filing | Apr 20, 2017 | — |
| DFAN14A | Filing | Apr 20, 2017 | — |
| DFAN14A | Filing | Apr 18, 2017 | — |
| DFAN14A | Filing | Apr 17, 2017 | — |
| DFAN14A | Filing | Apr 17, 2017 | — |
| DFAN14A | Filing | Apr 13, 2017 | — |
| DFAN14A | Filing | Apr 12, 2017 | — |
| DFAN14A | Filing | Apr 12, 2017 | — |
| DFAN14A | Filing | Apr 12, 2017 | — |
| DFAN14A | Filing | Apr 11, 2017 | — |
| DFAN14A | Filing | Apr 10, 2017 | — |
| DFAN14A | Filing | Apr 10, 2017 | — |
| DFAN14A | Filing | Apr 6, 2017 | — |
| CT ORDER | Filing | Apr 6, 2017 | — |
| CT ORDER | Filing | Apr 6, 2017 | — |
| DFAN14A | Filing | Apr 4, 2017 | — |
| DFAN14A | Filing | Mar 30, 2017 | — |
| DFAN14A | Filing | Mar 29, 2017 | — |
| DFAN14A | Filing | Mar 27, 2017 | — |
| DFAN14A | Filing | Mar 27, 2017 | — |
| DFAN14A | Filing | Mar 27, 2017 | — |
| DFAN14A | Filing | Mar 23, 2017 | — |
| DEFC14A | Filing | Mar 22, 2017 | — |
| DEFC14A | Filing | Mar 22, 2017 | — |
| DFAN14A | Filing | Mar 20, 2017 | — |
| PRRN14A | Filing | Mar 20, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 17, 2017 | — |
| PREC14A | Filing | Mar 13, 2017 | — |
| CORRESP | Letter to the SEC | Mar 7, 2017 | — |
| PREC14A | Filing | Mar 7, 2017 | — |
| UPLOAD | Letter from the SEC | Jan 10, 2017 | — |
| CORRESP | Letter to the SEC | Dec 14, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 5, 2016 | — |
| CORRESP | Letter to the SEC | Nov 1, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 25, 2016 | — |
| CORRESP | Letter to the SEC | Sep 22, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 14, 2016 | — |
| SC TO-I/A | Filing | Dec 7, 2015 | — |
| SC TO-I/A | Filing | Dec 2, 2015 | — |
| SC TO-I/A | Filing | Nov 23, 2015 | — |
| SC TO-I/A | Filing | Nov 12, 2015 | — |
| SC TO-I/A | Filing | Nov 10, 2015 | — |
| SC TO-I/A | Filing | Nov 5, 2015 | — |
| SC TO-I | Filing | Oct 30, 2015 | — |
| SC TO-C | Filing | Oct 29, 2015 | — |
| SC TO-C | 8-k | Oct 28, 2015 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2015 | — |
| CORRESP | Letter to the SEC | Jul 27, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2015 | — |
| CT ORDER | Filing | Oct 1, 2014 | — |
| CT ORDER | Filing | Oct 1, 2014 | — |
| UPLOAD | Letter from the SEC | May 15, 2014 | — |
| CORRESP | Letter to the SEC | Apr 15, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 2, 2014 | — |
| CT ORDER | Filing | Jul 15, 2013 | — |
Showing 69 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INVA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Burlingame, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1080014
- Former names
- THERAVANCE INC (until Dec 7, 2015); ADVANCED MEDICINE INC (until Aug 2, 2000)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.